Nutrition regime for patients with exocrine pancreatic insufficiency

  • Phạm Thảo Tố Bệnh viện Trung ương Quân đội 108
  • Nguyễn Đình Phú Bệnh viện Trung ương Quân đội 108
  • Nguyễn Thị Vân Anh Bệnh viện Trung ương Quân đội 108
  • Nguyễn Văn Thái Bệnh viện Trung ương Quân đội 108

Main Article Content

Keywords

Exocrine pancreatic insufficiency, malabsorption

Abstract

The exocrine pancreas secretes digestive enzymes, bicarbonate, and fluid into the lumen of the duodenum to digest food and absorb nutrients. Exocrine pancreatic insufficiency (EPI) causes poor digestion of food, malabsorption of nutrients, weight loss, and malnutrition. Malnutrition causes immunosuppression, increased infections, cardiovascular events, treatment costs, reduced quality of life, and reduced survival time. The implementation of appropriate nutrition and the use of pancreatic enzyme replacement drugs are essential in the treatment of patients with exocrine pancreatic enzyme deficiency, in order to ensure food digestion, improve digestive symptoms, help to fully absorb nutrients, prevent or improve malnutrition, increase the quality of life, prolong survival time.

Article Details

References

1. Diéguez-Castillo, Carmelo et al (2020) State of the art in exocrine pancreatic insufficiency. Medicina (Kaunas, Lithuania) 56(10): 523. doi:10.3390/ medicina56100523.
2. Forsmark, Chris E (2018) Diagnosis and management of exocrine pancreatic insufficiency. Current treatment options in gastroenterology vol. 16(3): 306-315. doi:10.1007/ s11938-018-0186-y
3. Arvanitakis M et al (2020) ESPEN guideline on clinical nutrition in acute and chronic pancreatitis. Clinical Nutrition 39: 612-631.
4. Mai Hồng Bàng, Hoàng BH, Tâm LN và cộng sự (2020) Khuyến cáo về chẩn đoán và điều trị thiểu năng tụy ngoại tiết tại Việt Nam. Tạp chí Khoa học Tiêu hóa Việt Nam 9 (61).
5. Freedman, Steven D (2017) Options for addressing exocrine pancreatic insufficiency in patients receiving enteral nutrition supplementation. The American journal of managed care 23(12): 220-228.
6. Cystic Fibrosis Foundation Patient Registry 2015 annual data report. https://www.cff.org/Our-Research/CF-Patient-Registry/2015-Patient-Registry-Annual-Data-Report.pdf. Published August 1, 2016. Accessed May 5, 2017.
7. Nicolo M, Stratton KW, Rooney W, Boullata J (2013) Pancreatic enzyme replacement therapy for enterally fed patients with cystic fibrosis. Nutr Clin Pract. 28(4): 485-489. doi: 10.1177/0884533613491786.
8. Shah ND, Limkelkai BN (2017) The use of medium-chain triglycerides in gastrointestinal disorders. Practical Gastroenterology 16: 20-28.
9. Capurso G et al (2019) Exocrine pancreatic insufficiency: Prevalence, diagnosis, and management. Clin Exp Gastroenterol 12: 129-139.
10. De la Iglesia D et al (2019) Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: A prospective, longitudinal cohort study. J Gastroenterol Hepatol 34(1): 277-283.
11. De la Iglesia-Garcia D et al (2018) Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis. J Clin Gastroenterol 52(8): 63-72.
12. Trang T, Chan J, Graham DY (2014) Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21st century. World J Gastroenterol 20(33): 11467-11485. doi: 10.3748/wjg.v20.i33.11467.
13. Hart PA, Conwell DL (2015) Diagnosis of exocrine pancreatic insufficiency. Curr Treat Options Gastroenterol 13(3): 347-353. doi: 10.1007/s11938-015-0057-8.
14. Lindkvist B (2013) Diagnosis and treatment of pancreatic exocrine insufficiency. World J Gastroenterol 19(42): 7258-7266. doi: 10.3748/wjg.v19.i42.7258.
15. Berry AJ (2014) Pancreatic enzyme replacement therapy during pancreatic insufficiency. Nutr Clin Pract 29(3): 312-321. doi: 10.1177/08845 33614527773.
16. Struyvenberg MR, Martin CR, Freedman SD (2017) Practical guide to exocrine pancreatic insufficiency - breaking the myths. BMC Med 15(1): 29. doi: 10.1186/s12916-017-0783-y.
17. Schwarzenberg SJ, Hempstead SE, McDonald CM, et al (2016) Enteral tube feeding for individuals with cystic fibrosis: Cystic Fibrosis Foundation evidence-informed guidelines. J Cyst Fibros 15(6): 724-735. doi: 10.1016/j.jcf.2016.08.004.
18. Woestenenk JW, van der Ent CK, Houwen RH (2015) Pancreatic enzyme replacement therapy and coefficient of fat absorption in children and adolescents with cystic fibrosis. J Pediatr Gastroenterol Nutr 61(3): 355-360. doi: 10.1097/MPG.0000000000000784.
19. Dominguez-Muñoz JE (2018) Diagnosis and treatment of pancreatic exocrine insufficiency. Curr Opin Gastroenterol 35(5): 349-354.
20. Phillips ME et al (2021) Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines. BMJ open gastroenterology 8(1): 000643. doi:10.1136/ bmjgast-2021-000643.